Top 50 Biotechnology VC (Venture Capital) Funds in Spain in January 2026

Investor	Biotechnology Spain investments
Centre for the Development of Industrial Technology (CDTI)	24
Criteria Venture Tech	15
SODENA	14
Inveready	13
ENISA	12
Invivo Capital Partners	10
Clave	10
Ysios Capital	9
ICF Capital	9
Capital Cell	9
Asabys Partners	9
Alta Life Sciences	8
Bullnet Capital	7
CRB Inverbío	7
BeAble Capital	7
Xesgalicia	7
BStartup	5
Moira Capital Partners	5
Gestion De Capital Riesgo Del Pais Vasco	4
CDTI	4
Angels Capital	4
Amadeus Capital Partners	4
Clave Mayor	4
Seed Capital Bizkaia	3
Grow Venture Partners	3
Clave Capital	3
AdBio partners	3
SOSV	3
Grupo Ferrer Internacional	2
Eatable Adventures	2
Amino Collective	2
Healthequity	2
Faber	2
Elaia	2
Nara Capital	2
Blue Horizon Corporation	2
Columbus Venture Partners	2
APEX Ventures	2
BoxOne Ventures	2
Kinled Holding	2
Speedinvest	2
Josep Carreras Leukaemia Research Institute	2
CDTI Innovación's INNVIERTE program	2
Fitalent	2
AVANTECA Partners	2
Monte Carlo Capital	2
Demium Capital	2
Kereon Partners	2
Archipelago Next	2
Fondo Bolsa Social	2

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
Niche Mobility — Niche developes electric propulsion systems for e-bicycles with integrated digital gearchange.
UPTECH SENSING — UPTECH SENSING designs, manufactures, and operates monitoring systems based on fiber optic solutions.

Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.

SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.

Investment focus

Health Care, Biotechnology, Software
Debt Financing, Funding Round, Seed
Spain, United Kingdom

Portfolio highlights

Ubyko — Ubyko focuses on robotics and automation solutions for last-mile logistics in urban retail environments.
Muxunav — Muxunav specialize in digital payment systems, they might be working on technologies like mobile payment solutions, online transaction systems, digital wallets, or even blockchain-based payment methods.
Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health

Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.

Investment focus

Software, Biotechnology, Health Care
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Orbidi — Orbidi is a digital marketing agency that provides SEO, website building, and Google Maps integration services for businesses.
Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

HOLO — Holo Health is a startup revolutionizing personalized health by blending advanced laboratory testing, real-time tracking from wearable devices, and artificial intelligence to deliver highly customized health insights and actionable plans.
Supercubo — Supercubo is a Spanish startup based in Seville, founded with the goal of promoting healthy lifestyle habits by facilitating the creation of outdoor functional training centers through a scalable, low-risk, and cost-effective solution.Our project aims to both ease access for entrepreneurs and foster the growth of our community.The company wasfounded in December 2023 (starting operations in March 2024), and to date, the proof-of-concept for our three business lines has already been implemented and validated: • Own gyms • Franchisees • Third-party sales
Modular DS — Modular DS enables WordPress professionals and businesses to save time managing their websites.

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Biotechnology, Health Care, Life Science
Seed, Funding Round, Series A
Spain, France, Belgium

Portfolio highlights

Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.

Clave is an investment management company.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Series A
Spain, Chile, Switzerland

Portfolio highlights

Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
Corify Care — CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to introduce in the market a novel medical device to non-invasively map cardiac arrhythmias in real time. This novel technology will improve the treatment in more than 10 million of atrial fibrillation patients only in Europe. Our non-invasiveelectro-anatomical mapping systems displays the activation patterns in each point of the heart without the need of invasive catheters, allowing the possibility to map all atrial fibrillation patients even during a regular visit to the cardiologist. CORIFY Care is located in Madrid, Spain, one of the most attractive places to work/live on the South of Europe.
Genbioma — Genbioma is a biotechnology company transforming microbiome science into clinically validated postbiotics that support metabolic health, improve glucose control, and naturally activate the GLP-1 pathway.

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.

ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.

Investment focus

Software, Biotechnology, Health Care
Debt Financing, Funding Round, Seed
Spain, United States, Mexico

Portfolio highlights

Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.

Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Seed, Funding Round
Spain, United States, United Kingdom

Portfolio highlights

MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Medical Device, Health Care
Series A, Seed, Series B
Spain, France, Belgium

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Investment focus

Software, Information Technology, Enterprise Software
Funding Round, Seed, Series A
Spain, United States, Mexico

Portfolio highlights

wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
Bioherent — Photonic biosensors for drug allergy diagnosis
Inspiration-Q — Quantum-inspired optimization for financial markets

CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
Spain, Mexico

Portfolio highlights

Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.

BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.

Investment focus

Biotechnology, Manufacturing, Product Management
Pre-Seed, Seed, Funding Round
Spain, Italy

Portfolio highlights

Reinforce 3D — Reinforce3D develops proprietary technology for reinforcing 3D-printed parts, called the continuous fiber injection process (CFIP)
ALCYON PHOTONICS — ALCYON
Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Funding Round, Pre-Seed
Spain, Mexico, United States

Portfolio highlights

Kloutit — Generate personalized defenses with Kloutit's AI. Recover revenue, maximize your ROI, and streamline your team's chargeback management efficiently.
Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.

Moira Capital Partners is private equity firm

Investment focus

Biotechnology, Information Technology, 3D Technology
Funding Round, Series A, Private Equity
Spain

Portfolio highlights

NeuronUP — NeuronUP is a platform that provides professionals the ability to access real, when and where they want their exercise routines and their patients time manager and interact directly with their team of professionals in a specialized environment. All this generates a continuous updating of information and content platform, arising from theinter-professional dialogue.
Voovio — Voovio's Simulation Software enables the process industry to avoid errors during SOP execution, reducing downtime & increasing safety in operations & maintenance.
Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.

GestiÃ³n de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la PromociÃ³n y ReconversiÃ³n Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Seed, Series A
Spain

Portfolio highlights

Irisbond — Irisbond creates a new way for humans to communicate through precision eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Developed for use in mobile devices, automotive, smart homes, robotics, scientific,healthcare and manufacturing, eye tracking technology lets you learn, play, work and communicate with your eyes. A pioneer in the assistive technology market, Irisbond’s eye tracking solutions are based on years of R&D in cooperation with Vicomtech, a leader in the field of artificial vision. For more information about the power of the eyes, go to www.irisbond.com/en
InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
Inmedical Therapeutics — Inmedical Therapeutics is centered on the creation of the Covergel product, which is intended to avoid difficulties in therapeutic endoscopies

Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Debt Financing
Spain, United States, Mexico

Portfolio highlights

Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.

Investment focus

Software, E-Commerce, Health Care
Seed, Angel, Funding Round
Spain, United States, Ireland

Portfolio highlights

Internxt — Stand for privacy, switch to Internxt. Internxt's open-source cloud storage services protect your right to privacy. Internxt Drive, Meet, Mail, Antivirus, Cleaner, Send, and more
VICO Ahorro — VICO Ahorro uses a digital system that evaluates, compares, and automatically manages the best market offers to help consumers save money on regular costs like energy, insurance, and telecommunications.
ODOS — Carbon Harvesters is an ag-tech start-up that increases the resilience of rural communities by facilitating cost-effective decarbonisation of the dairy sector.

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Inephany — Inephany - We build systems to train AI agents specialised in optimising Neural Networks, such as LLMs and other Generative AI.
Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Biotechnology, Software, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.

Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de InnovaciÃ³n y PromociÃ³n EconÃ³mica de la DiputaciÃ³n Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.

Investment focus

Software, Biotechnology, Manufacturing
Seed, Funding Round, Series A
Spain, Mexico, Belgium

Portfolio highlights

coometes — coometes offer social institutions a comprehensive solution for managing food aid and basic necessities for vulnerable persons.
Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.
Emica Solar — Emica Solar is a company which develops the floating solar energy.

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Investment focus

Health Care, Artificial Intelligence, Biotechnology
Pre-Seed, Funding Round, Seed
Spain

Portfolio highlights

Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
SHINEPHI — Shinephi's vision is to change the state-of-the-art in nano-characterization and nano-fabrication to improve yield and expedite production in semiconductor manufacturing.
Virtest Technologies — Virtest Technologies is an innovation firm focused on personalized medicine, providing computational models, simulations, and image processing solutions to aid surgeons and medical device companies in testing products, enhancing decision-making, and improving clinical outcomes.

Clave Capital is an independent asset management company that specializes in investment strategy.

Investment focus

Biotechnology, Health Diagnostics, Health Care
Seed, Funding Round
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Nanological — Ultra-fast Identification of Bacteria for Sepsis Diagnosis - Multiparametric characterization of mass, size and optical absorption through optical and mechanical measurements to achieve real-time direct pathogen identification.
ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.

Investment focus

Biotechnology, Wellness, Biopharma
Series A, Funding Round
Spain

Portfolio highlights

Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
ABAC Therapeutics — Akses SURGA77 dengan mudah melalui link login alternatif resmi yang selalu aktif. Dengan RTP tertinggi dan peluang menang yang menggiurkan, Anda dapat merasakan sensasi bermain di bandar slot gacor hari ini. Nikmati berbagai pilihan permainan yang menarik dan fitur bonus yang menguntungkan, menjadikan setiap putaran penuh dengan potensi kemenangan. Bergabunglah sekarang dan raih kesempatan untuk memenangkan hadiah besar!

We identify and support the most innovative European food startups and help them to thrive in the global market

Investment focus

Food and Beverage, Food Processing, Agriculture
Seed, Series A
Spain, Italy

Portfolio highlights

Innomy — We developed a new generation of meat and take care of the planet.
FoodSeed — FoodSeed, the national Agrifoodtech program in Italy, along with CDP Venture Capital Sgr, Fondazione Cariverona, and UniCredit.
Foreverland — Foreverland Food is an Italian food-tech startup.

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Investment focus

Health Care, Biotechnology, Medical
Seed, Pre-Seed, Series A
United States, Germany, United Kingdom

Portfolio highlights

Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics

Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has ateam of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series D
Spain, Switzerland

Portfolio highlights

SANIFIT — CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.

Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Pre-Seed, Series A
Portugal, United States, United Kingdom

Portfolio highlights

YPLASMA — YPlasma, an INTA spin-off, develops plasma actuators for ionic flow control, enabling advancements in Energy and Electronics.
RESONIKS — It's data that drives resilient and sustainable supply chains. Implement SUPPLYZ solutions to gather real-time inventory data for your products and materials and use this data to automate your processes, offer new services and prevent supply chain disruptions. SUPPLYZ can be implemented for both industrial and consumer applications
Zymvol Biomodeling — Physics-AI hyperrealistic enzyme discovery. ZYMVOL helps R&D managers uncover hidden opportunities and screen areas overlooked by traditional methods.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

Pili — PiLi biofabricates a sustainable alternative to create renewable inks to replace their toxic, non-biological, and non-recyclable versions.Pili was born from the reunion of a biologist, a designer, and a financial analyst at the biohacker space La Paillasse in Paris and with the creation of the first pen fed by bacteria. Its team is nowdedicated to providing the colors from micro-organisms to offer a sustainable alternative to fossil resources.
Djust — DJUST is the dedicated solution that helps companies launch their B2B eCommerce and eProcurement platforms faster
SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

Investment focus

Biotechnology, Life Science, Medical
Seed, Funding Round
Spain

Portfolio highlights

Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Germany

Portfolio highlights

WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
foodforecast — AI supported solution to reduce food waste.

Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Series A, Series B
Spain, United States, United Kingdom

Portfolio highlights

Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
Artax Biopharma — Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Investment focus

Biotechnology, Health Care, Software
Seed, Pre-Seed, Series A
Canada, United States, United Kingdom

Portfolio highlights

Tornado — Digest information from thousands of public filings and your own documents with a versatile AI analyst, plus the reliability of full source attribution.
Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
TriplePlay — Roblox is reimagining the way people come together. Our platform enables anyone to create, connect, and express themselves in immersive 3D experiences.

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Investment focus

Biotechnology, Health Care, Financial Services
Seed, Funding Round, Series A
United Kingdom, United States, Switzerland

Portfolio highlights

Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.

Speedinvest is one of Europe’s most active early-stage venture capital funds, with more than €1.2bn in AuM and offices in Berlin, London, Munich, Paris, and Vienna. Our dedicated sector-focused teams (Climate Tech & Industrial Tech, Deep Tech, Fintech, Health & Bio, Marketplaces & Consumer Tech, SaaS & Infra) are the first to fundEMEA's most innovative pre-Seed and Seed tech startups. Our in-house operational experts and global network of industry leaders support our portfolio companies with growth, people (HR), market expansion, and more throughout every stage of their journeys. Bitpanda, GoStudent, Wayflyer, Open, CoachHub, Schüttflix, TourRadar, Adverity, and TWAICE are among our portfolio of 400+ companies.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
United Kingdom, Germany, Austria

Portfolio highlights

Vocca — Vocca manages your patient calls, bookings, and reminders 24/7 so your team spends less time on admin and more time on care. Tailored to all specialties. Trusted by thousands.
Finary — Finary is a platform that allows everybody to better track and manage their wealth.
Runware — Runware provides lightning-fast text-to-image and image-to-image generation speeds—0.3 seconds for SD 1.5 and 0.9 seconds for SDXL, all through one powerful API.

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Series B
Spain

Portfolio highlights

Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
Geniova — Geniova is a Spanish start-up that specializes in invisible orthodontics. The company’s patented method combines the power of a lingual nickel titanium arch and conventional aligners to obtain the fastest and most predictable technique in teeth alignment. Geniova’s innovative approach to orthodontics has earned it recognition as one of the mostinnovative start-ups globally in 2021. With remarkable international potential, Geniova is poised to revolutionize the field of orthodontics.”

Fitalent (FIT Investment Talent SCR Simplified Regime SL) is a venture capital firm formed in early 2011 and registered in the special register of the National Securities Market Commission (CNMV), which invests in technology companies and proven successful products , whose main asset are people and talent .Their mission is to assistentrepreneurs to get consolidated, profitable and leading companies in the technology market segment. They want to be financial and strategic partners of the companies in which they participate.

Investment focus

Biotechnology, Analytics, Artificial Intelligence
Seed, Funding Round, Series A
Spain

Portfolio highlights

Citibeats — Citibeats uses AI and cutting-edge technology to transform ethically sourced public opinions into real-time, data-driven actionable insights. Monitor trends surrounding sustainability, social risk, and more.
Boxmotions — Home delivery of bulky items (furniture, home appliances, large sports equipment, etc.) is a large, growing, segregated and underserved market. Retail and e-commerce are in need of a solution that delivers quality and end customer experience standards comparable to the most innovative regular parcel delivery solutions.Boxmotions' owntechnology stack and operational processes have been meticulously curated with an end-customer-centric approach, generating capabilities unseen in the bulky items logistics industry before: scheduled time slot deliveries controlled by the end customer, delivery times x5 faster than industry average, tailored technology-guided interactions, assembly/dissassembly services, and more. We connect demand's orders with a curated pool of existing, segregated supply while guiding the whole value chain through our technology and generating incremental operational efficiency. Such model entices supply and, at the same time, provides retail and e-commerce with a capability to boost end customer experience with only competitive logistics costs.The basis of our technology stack and supply curation comes originally from an initial business line: an on-demand-storage solution for personal logistics. In our journey towards a larger market, we have always maintained our vision of making urban life easier, and more sustainable.
Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

A privately held asset management company that invests in early-stage life science companies.

Investment focus

Biotechnology, Health Care, Security
Seed, Funding Round
Spain, Switzerland

Portfolio highlights

Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.

Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.

Investment focus

Medical Device, Financial Services, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

1849 Bio — 1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
Scout AI — Scout AI is building the robotic foundation model for defense.
Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!

Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Spain, Portugal, Poland

Portfolio highlights

Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
Aino — AIno is an AI GIS platform for location data analysis and map creation. Perform site analysis in minutes for urban planning and real estate projects.

> smart projects

Investment focus

Health Care, Cooking, Medical
Seed, Funding Round
Spain

Portfolio highlights

Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally

Archipelago Next support and promote the entrepreneurial ecosystem.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Funding Round, Pre-Seed
Spain, United States

Portfolio highlights

Ciudadela — Ciudadela is a property management company that offers digital platform for administrating and managing properties.
Hotelverse — Hotelverse allows customers search over hotels on their platform and book rooms as per their requirements.
Break-Event — Break-Event aids music industry professionals and businesses by transforming information into knowledge. They are dedicated to providing the product, enabling customers to make wiser decisions, and ensuring the performance of events.

Fondo Bolsa Social venture capital fund that invests into startups or new companies that generates positive social and environmental impact.

Investment focus

SaaS, Software, B2B
Seed, Funding Round, Pre-Seed
Spain

Portfolio highlights

CubicUp — CubicUp is the person of confidence that accompanies you in your project of Reform from Begin to Finish.
Punto Health — A digital solution for management of Alzheimer's disease and other dementias. PuntoClinic for healthcare providers and PuntoCare for patients and carers.
Likes Telecom — Likes Telecom offers white label solutions for telco and related sectors, focusing on rural areas to reduce the digital divide through artificial intelligence and cloud-based solutions.